GeoVax to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update

NEXT STORY
G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA™ (trilaciclib) in Clinical Lung Cancer
PREV STORY
Antares Pharma Appoints Dr. Peter Richardson as Executive Vice President, Research and Development and Chief Medical Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sunesis to Host Conference Call on November 2nd to Discuss Third Quarter 2017 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Oct. 27, 2017 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) ...

author_avatar
NASDAQ Market News

Novan Appoints Tomoko Maeda-Chubachi, MD, PhD, MBA as Chief Medical Officer

author_avatar
NASDAQ Market News

Global Transplant Diagnostics Market Report (2018-2023) – The Molecular Assay Technology Segment is Expected to Account for the Largest Share of the Market

Dublin, July 12, 2018 (GLOBE NEWSWIRE) -- The "Transplant Diagnostics Market by Technology, Product, ...

author_avatar
NASDAQ Market News